PF-07976016
Sponsors
Pfizer
Conditions
HealthyHealthy Male VolunteersObesityOverweight
Phase 1
A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The Body in Healthy Adults
CompletedNCT06106009
Start: 2023-10-27End: 2024-08-19Updated: 2024-09-23
Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity
TerminatedNCT06910839
Start: 2025-03-13End: 2025-05-20Updated: 2025-08-07
A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men
CompletedNCT07015918
Start: 2025-06-04End: 2025-08-14Updated: 2025-09-10